ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 106 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,756,000 | +166.9% | 100,000 | +274.5% | 0.21% | -24.7% |
| Q4 2017 | $658,000 | -68.7% | 26,700 | -67.2% | 0.28% | -64.9% |
| Q3 2017 | $2,104,000 | +69.7% | 81,500 | +78.2% | 0.80% | +51.9% |
| Q2 2017 | $1,240,000 | -9.1% | 45,740 | 0.0% | 0.52% | -4.4% |
| Q1 2017 | $1,364,000 | -60.3% | 45,740 | -63.9% | 0.55% | -67.3% |
| Q4 2016 | $3,439,000 | +402.8% | 126,700 | +374.5% | 1.67% | +594.6% |
| Q3 2016 | $684,000 | -38.3% | 26,700 | -55.5% | 0.24% | -86.2% |
| Q2 2016 | $1,108,000 | – | 60,000 | – | 1.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |